Preexposure prophylaxis for HIV prevention in a large integrated health care system: adherence, renal safety, and discontinuation

JL Marcus, LB Hurley, CB Hare… - JAIDS Journal of …, 2016 - journals.lww.com
Background: Placebo-controlled and open-label studies have demonstrated the safety and
efficacy of daily oral preexposure prophylaxis (PrEP) in preventing HIV infection, but data …

Racial/ethnic and HIV risk category disparities in preexposure prophylaxis discontinuation among patients in publicly funded primary care clinics

HM Scott, M Spinelli, E Vittinghoff, A Morehead-Gee… - Aids, 2019 - journals.lww.com
Objective: Dissemination of preexposure prophylaxis (PrEP) is a priority for reducing new
HIV infections, especially among vulnerable populations. However, there are limited data …

Successful implementation of HIV preexposure prophylaxis: lessons learned from three clinical settings

JL Marcus, JE Volk, J Pinder, AY Liu, O Bacon… - Current HIV/AIDS …, 2016 - Springer
The past 3 years have marked a transition from research establishing the safety and efficacy
of HIV preexposure prophylaxis (PrEP) to questions about how to optimize its …

Packaging PrEP to prevent HIV: an integrated framework to plan for pre-exposure prophylaxis implementation in clinical practice

K Underhill, D Operario, MR Skeer… - JAIDS Journal of …, 2010 - journals.lww.com
PrEP entails providing HIV-negative individuals with ARV drugs, and it is widely anticipated
as one of the most promising new prevention strategies. The PrEP drugs that have been …

Evolving models and ongoing challenges for HIV preexposure prophylaxis implementation in the United States

KH Mayer, PA Chan, RR Patel, CA Flash… - JAIDS Journal of …, 2018 - journals.lww.com
Background: The use of preexposure prophylaxis (PrEP) for HIV prevention was approved
by the Food and Drug Administration in 2012, but delivery to at-risk persons has lagged …

Preexposure prophylaxis for the prevention of HIV infection: evidence report and systematic review for the US Preventive Services Task Force

R Chou, C Evans, A Hoverman, C Sun, T Dana… - Jama, 2019 - jamanetwork.com
Importance Effective prevention strategies for HIV infection are an important public health
priority. Preexposure prophylaxis (PrEP) involves use of antiretroviral therapy (ART) daily or …

Impact of insurance coverage on utilization of pre-exposure prophylaxis for HIV prevention

RR Patel, L Mena, A Nunn, T McBride, LC Harrison… - PloS one, 2017 - journals.plos.org
Pre-exposure prophylaxis (PrEP) can reduce US HIV incidence. We assessed insurance
coverage and its association with PrEP utilization. We reviewed patient data at three PrEP …

Retention in care outcomes for HIV pre‐exposure prophylaxis implementation programmes among men who have sex with men in three US cities

PA Chan, L Mena, R Patel… - Journal of the …, 2016 - Wiley Online Library
Introduction Despite the efficacy of pre‐exposure prophylaxis (PrEP) in preventing HIV
transmission, few studies have evaluated PrEP use and retention in care outcomes in real …

Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort …

M Gandhi, DV Glidden, K Mayer, M Schechter… - The lancet HIV, 2016 - thelancet.com
Background As pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate and
emtricitabine for the prevention of HIV infection is rolled out internationally, strategies to …

Persistence with human immunodeficiency virus pre-exposure prophylaxis in the United States, 2012–2017

YLA Huang, G Tao, DK Smith… - Clinical Infectious …, 2021 - academic.oup.com
Background Daily oral pre-exposure prophylaxis (PrEP) is highly effective in preventing
human immunodeficiency virus (HIV) infection if used adherently throughout periods of HIV …